The function and application of sh3rf2 in the preparation of drugs for the treatment of non-alcoholic fatty liver disease and/or type 2 diabetes
A non-alcoholic, fatty liver disease technology, applied in the direction of application, drug combination, gene therapy, etc., can solve the problems of aggravated liver damage and achieve the effect of improving fatty liver disease
Active Publication Date: 2021-05-04
WUHAN UNIV
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
On the other hand, if type II diabetes is poorly controlled or fully developed, it will promote the formation of fatty liver and aggravate liver damage
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0025] The present invention will be further elaborated through the following detailed description in conjunction with the accompanying drawings and specific embodiments.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention discloses the function and application of Sh3rf2 in the preparation of medicines for treating non-alcoholic fatty liver disease and / or type II diabetes. The present invention takes Sh3rf2 gene knockout mice and wild-type C57 mice as experimental objects, and through the obesity mouse model induced by a high-fat and high-cholesterol diet, it is found that compared with the wild-type C57 mice of the control group, the Sh3rf2 gene knockout mice Body weight gain, mouse liver weight, liver / body weight, and pathological staining of lipid components all showed that the Sh3rf2‑KO mice in the HFHC group had significantly severe fatty liver lesions and increased lipid accumulation. These results indicated that Sh3rf2 gene knockout significantly worsened non Disease course in alcoholic fatty liver disease. Aiming at the above-mentioned effects of Sh3rf2, it can be used to prepare medicines for preventing, alleviating and / or treating non-alcoholic fatty liver disease and / or type II diabetes.
Description
technical field [0001] The invention belongs to the field of gene function and application, and in particular relates to the function and application of (SH3 domain-containingRING finger protein 2, Sh3rf2)Sh3rf2 in the preparation of medicines for treating non-alcoholic fatty liver disease and / or type II diabetes. Background technique [0002] With the increase of aging population, urbanized life and changes in lifestyle, obesity, non-alcoholic fatty liver disease, metabolic syndrome and diabetes and other metabolic abnormalities have increased dramatically, and have now become an important hazard to global public health. [0003] The liver is one of the most important organs of glucose metabolism and the center of substance metabolism. It has many important physiological functions, such as the synthesis and decomposition of glucose, lipid synthesis and decomposition, bile synthesis and secretion, etc. Fatty liver refers to the pathological changes caused by excessive accumu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00C12N15/00A01K67/027
CPCA01K67/0276A01K67/0278A01K2217/072A01K2217/075A01K2227/105A01K2267/0362A61K45/00A61P1/16A61P3/10A61P35/00
Inventor 李红良折志刚姬燕晓杨霞
Owner WUHAN UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com